Oak Ridge Investments’s BridgeBio Pharma BBIO Stock Holding History

Oak Ridge Investments’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.84M	Buy	38,190 +298	+0.8%	+$20.9K	0.16%	87
2026 Q1	$2.81M	Buy	37,892 +4,288	+13%	+$311K	0.19%	77
2025 Q4	$2.57M	Buy	33,604 +5,669	+20%	+$372K	0.16%	76
2025 Q3	$1.45M	Sell	27,935 -558	-2%	-$27.2K	0.09%	107
2025 Q2	$1.23M	Buy	+28,493	New	+$1.04M	0.09%	110

Other funds holding BBIO

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Oak Ridge Investments's BBIO Position: Q2 2026 in Review

Oak Ridge Investments increased its BridgeBio Pharma (BBIO) stake by 0.79% in Q2 2026, buying an estimated $20.9K and bringing the position to 38,190 shares worth $2.84M. The position accounts for 0.16% of the portfolio, ranked #87.

Oak Ridge Investments first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 73 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Oak Ridge Investments held 38,190 shares of BridgeBio Pharma worth $2.84M as of Q2 2026.
Oak Ridge Investments bought 298 BridgeBio Pharma shares in Q2 2026, an estimated $20.9K.
BridgeBio Pharma made up 0.16% of Oak Ridge Investments's portfolio in Q2 2026, its #87 holding.
Oak Ridge Investments first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
73 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.